Kanamalı Kardiyovasküler Hastada Sezaryen Anestezi Yönetimi
Synopsis
Nowadays, although the rate of pregnancy in women with congenital and acquired cardiovascular diseases is increasing, acquired heart diseases constitute the main cause of cardiac death during pregnancy. Severe obstetric conditions leading to maternal hemorrhage, such as placenta previa, placental abruption, and uterine rupture, complicate anesthetic management in pregnant patients with cardiovascular disease and significantly increase the risk of life-threatening morbidity and mortality. Therefore, patient follow-up and delivery planning should be carried out with a multidisciplinary approach in well-equipped centers staffed by specialists in obstetrics, cardiology, pediatrics, and anesthesiology, where adult and pediatric intensive care conditions are adequate. When selecting the cesarean anesthesia technique, the effects of pregnancy physiology on the patient's specific cardiac anatomy and pathophysiology must be thoroughly evaluated preoperatively. In hemodynamically stable patients without active bleeding, slow-induction epidural anesthesia or neuraxial techniques, which affect hemodynamic stability less, may be preferred while keeping in mind the risk of hypotension secondary to sympathetic blockade. However, in high-risk cases with active bleeding, unstable hemodynamics, mechanical valve replacement receiving anticoagulants, or severe placental abruption and uterine rupture, emergency cesarean section under general anesthesia is mandatory. In general anesthesia administration, pre-oxygenation must be meticulously performed, slow induction should be applied, and cardiac shunt direction alongside systemic and pulmonary vascular resistance balances must be carefully maintained according to the patient's specific pathology.
References
Thompson JL, Kuklina EV, Bateman BT, Callaghan WM, James AH, Grotegut CA. Medical and Obstetric Outcomes Among Pregnant Women With Congenital Heart Disease. Obstetrics and gynecology. 2015;126(2):346-54.
Knight M, Nair M, Tuffnell D, Kenyon S, Shakespeare J, Brocklehurst P, et al. Saving Lives, Improving Mothers' Care: Surveillance of maternal deaths in the UK 2012-14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-14: Oxuniprint; 2016.
Ashrafi R, Curtis SL. Heart Disease and Pregnancy. Cardiology and therapy. 2017;6(2):157-73.
Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2003;13(3):175-90.
Ananth CV, Smulian JC, Vintzileos AM. The association of placenta previa with history of cesarean delivery and abortion: a metaanalysis. American journal of obstetrics and gynecology. 1997;177(5):1071-8.
Fan D, Wu S, Liu L, Xia Q, Wang W, Guo X, et al. Prevalence of antepartum hemorrhage in women with placenta previa: a systematic review and meta-analysis. Scientific reports. 2017;7:40320.
Cotton DB, Read JA, Paul RH, Quilligan EJ. The conservative aggressive management of placenta previa. American journal of obstetrics and gynecology. 1980;137(6):687-95.
Gibbins KJ, Einerson BD, Varner MW, Silver RM. Placenta previa and maternal hemorrhagic morbidity. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2018;31(4):494-9.
Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. American journal of obstetrics and gynecology. 2008;199(1):49.e1-8.
Ananth CV, Keyes KM, Hamilton A, Gissler M, Wu C, Liu S, et al. An international contrast of rates of placental abruption: an age-period-cohort analysis. PloS one. 2015;10(5):e0125246.
Cheng HT, Wang YC, Lo HC, Su LT, Lin CH, Sung FC, et al. Trauma during pregnancy: a population-based analysis of maternal outcome. World journal of surgery. 2012;36(12):2767-75.
Kasai M, Aoki S, Ogawa M, Kurasawa K, Takahashi T, Hirahara F. Prediction of perinatal outcomes based on primary symptoms in women with placental abruption. The journal of obstetrics and gynaecology research. 2015;41(6):850-6.
de Lloyd L, Bovington R, Kaye A, Collis RE, Rayment R, Sanders J, et al. Standard haemostatic tests following major obstetric haemorrhage. International journal of obstetric anesthesia. 2011;20(2):135-41.
Guiliano M, Closset E, Therby D, LeGoueff F, Deruelle P, Subtil D. Signs, symptoms and complications of complete and partial uterine ruptures during pregnancy and delivery. European journal of obstetrics, gynecology, and reproductive biology. 2014;179:130-4.
Main EK, Goffman D, Scavone BM, Low LK, Bingham D, Fontaine PL, et al. National Partnership for Maternal Safety: Consensus Bundle on Obstetric Hemorrhage. Obstetrics and gynecology. 2015;126(1):155-62.
Shields LE, Smalarz K, Reffigee L, Mugg S, Burdumy TJ, Propst M. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products. American journal of obstetrics and gynecology. 2011;205(4):368.e1-8.
Akpinar O. [Pregnancy and heart valve disease]. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology. 2009;9 Suppl 1:25-34.
Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). European heart journal. 2011;32(24):3147-97.
Goldszmidt E, Macarthur A, Silversides C, Colman J, Sermer M, Siu S. Anesthetic management of a consecutive cohort of women with heart disease for labor and delivery. International journal of obstetric anesthesia. 2010;19(3):266-72.
Boyle RK. Anaesthesia in parturients with heart disease: a five year review in an Australian tertiary hospital. International journal of obstetric anesthesia. 2003;12(3):173-7.
Yıldırım Ö, Günüşen İ, Sargın A, Fırat V, Karaman S. The Evaluation of Applied Anaesthetic Techniques for Caesarean in Parturients with Cardiac Diseases: Retrospective Analysis. Turkish journal of anaesthesiology and reanimation. 2014;42(6):326-31.
Bonnet MP, Deneux-Tharaux C, Bouvier-Colle MH. Critical care and transfusion management in maternal deaths from postpartum haemorrhage. European journal of obstetrics, gynecology, and reproductive biology. 2011;158(2):183-8.
Buhre W, Disma N, Hendrickx J, DeHert S, Hollmann MW, Huhn R, et al. European Society of Anaesthesiology Task Force on Nitrous Oxide: a narrative review of its role in clinical practice. British journal of anaesthesia. 2019;122(5):587-604.
Connolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of great arteries. Journal of the American College of Cardiology. 1999;33(6):1692-5.